Author

Katherine Emilie Rhoades Smith

Observed name: Smith, Katherine E.

Institution: Mayo Clinic

Observed institution: Mayo Clinic

ORCID: 0009-0004-5114-794X

Observed ORCID: 0009-0004-5114-794X

OpenAlex ID: A5129596194

PP01.08: Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

2026 · Sarah Waliany, Alissa J. Cooper, et al. · Journal of Thoracic Oncology · 1

MC1923: Phase II durvalumab plus lurbinectedin in platinum-resistant relapsed extensive-stage small cell lung cancer after prior chemoimmunotherapy (cohort B).

2026 · Konstantinos Leventakos, Anastasios Dimou, et al. · Journal of Clinical Oncology

Table S2 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

2026 · Sarah Waliany, Alissa J. Cooper, et al.

Table S1 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

2026 · Sarah Waliany, Alissa J. Cooper, et al.

Supplementary Data from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

2026 · Sarah Waliany, Alissa J. Cooper, et al.

Table S3 from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

2026 · Sarah Waliany, Alissa J. Cooper, et al.

Data from Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium

2026 · Sarah Waliany, Alissa J. Cooper, et al.

2025 · Bambra, Clare, Lynch, Julia, et al. · Directory of Open access Books (OAPEN Foundation)

Works count: 8

Citation count: 1

H-index: 1

I10-index: